日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/09/05 | 3,260 | 3,301 | 3,250 | 3,294 | +24 | +0.7% | 307,900 |
| 2025/09/04 | 3,276 | 3,276 | 3,233 | 3,270 | +3 | +0.1% | 194,800 |
| 2025/09/03 | 3,230 | 3,287 | 3,226 | 3,267 | +47 | +1.5% | 491,400 |
| 2025/09/02 | 3,235 | 3,286 | 3,220 | 3,220 | ±0 | ±0% | 519,000 |
| 2025/09/01 | 3,174 | 3,225 | 3,161 | 3,220 | +93 | +3% | 664,100 |
| 2025/08/29 | 3,110 | 3,142 | 3,107 | 3,127 | +32 | +1% | 315,900 |
| 2025/08/28 | 3,098 | 3,119 | 3,075 | 3,095 | -35 | -1.1% | 416,400 |
| 2025/08/27 | 3,142 | 3,144 | 3,117 | 3,130 | -23 | -0.7% | 267,500 |
| 2025/08/26 | 3,210 | 3,210 | 3,146 | 3,153 | -69 | -2.1% | 386,300 |
| 2025/08/25 | 3,245 | 3,273 | 3,211 | 3,222 | -4 | -0.1% | 205,900 |
| 2025/08/22 | 3,211 | 3,235 | 3,192 | 3,226 | +4 | +0.1% | 219,900 |
| 2025/08/21 | 3,240 | 3,244 | 3,215 | 3,222 | -25 | -0.8% | 262,800 |
| 2025/08/20 | 3,286 | 3,293 | 3,247 | 3,247 | -40 | -1.2% | 293,700 |
| 2025/08/19 | 3,261 | 3,288 | 3,243 | 3,287 | +16 | +0.5% | 264,700 |
| 2025/08/18 | 3,255 | 3,296 | 3,250 | 3,271 | +28 | +0.9% | 376,600 |
| 2025/08/15 | 3,251 | 3,264 | 3,215 | 3,243 | -23 | -0.7% | 283,100 |
| 2025/08/14 | 3,323 | 3,335 | 3,256 | 3,266 | -57 | -1.7% | 348,400 |
| 2025/08/13 | 3,334 | 3,342 | 3,287 | 3,323 | -11 | -0.3% | 315,800 |
| 2025/08/12 | 3,337 | 3,347 | 3,281 | 3,334 | +44 | +1.3% | 321,700 |
| 2025/08/08 | 3,270 | 3,294 | 3,221 | 3,290 | +34 | +1% | 339,000 |
| 2025/08/07 | 3,301 | 3,336 | 3,225 | 3,256 | -58 | -1.8% | 394,000 |
| 2025/08/06 | 3,320 | 3,333 | 3,303 | 3,314 | +17 | +0.5% | 242,600 |
| 2025/08/05 | 3,320 | 3,337 | 3,295 | 3,297 | +3 | +0.1% | 190,000 |
| 2025/08/04 | 3,265 | 3,305 | 3,265 | 3,294 | -9 | -0.3% | 223,500 |
| 2025/08/01 | 3,288 | 3,318 | 3,278 | 3,303 | +26 | +0.8% | 277,700 |
| 2025/07/31 | 3,249 | 3,282 | 3,245 | 3,277 | +41 | +1.3% | 341,300 |
| 2025/07/30 | 3,209 | 3,263 | 3,192 | 3,236 | +27 | +0.8% | 432,300 |
| 2025/07/29 | 3,153 | 3,219 | 3,146 | 3,209 | +20 | +0.6% | 272,900 |
| 2025/07/28 | 3,199 | 3,227 | 3,173 | 3,189 | -10 | -0.3% | 295,300 |
| 2025/07/25 | 3,222 | 3,222 | 3,173 | 3,199 | -32 | -1% | 366,800 |
| 2025/07/24 | 3,250 | 3,296 | 3,230 | 3,231 | +11 | +0.3% | 664,100 |
| 2025/07/23 | 3,071 | 3,241 | 3,067 | 3,220 | +184 | +6.1% | 879,100 |
| 2025/07/22 | 3,099 | 3,136 | 3,020 | 3,036 | -72 | -2.3% | 576,300 |
| 2025/07/18 | 3,127 | 3,148 | 3,088 | 3,108 | -20 | -0.6% | 328,600 |
| 2025/07/17 | 3,060 | 3,135 | 3,051 | 3,128 | +81 | +2.7% | 397,700 |
| 2025/07/16 | 3,019 | 3,052 | 3,006 | 3,047 | +34 | +1.1% | 419,500 |
| 2025/07/15 | 3,030 | 3,055 | 2,994 | 3,013 | +8 | +0.3% | 711,800 |
| 2025/07/14 | 2,993 | 3,034 | 2,967 | 3,005 | -215 | -6.7% | 1,217,300 |
| 2025/07/11 | 3,175 | 3,249 | 3,175 | 3,220 | +70 | +2.2% | 309,500 |
| 2025/07/10 | 3,151 | 3,159 | 3,117 | 3,150 | ±0 | ±0% | 331,600 |
| 2025/07/09 | 3,122 | 3,179 | 3,118 | 3,150 | +32 | +1% | 271,200 |
| 2025/07/08 | 3,090 | 3,127 | 3,081 | 3,118 | +28 | +0.9% | 284,900 |
| 2025/07/07 | 3,130 | 3,130 | 3,090 | 3,090 | -43 | -1.4% | 229,500 |
| 2025/07/04 | 3,141 | 3,158 | 3,124 | 3,133 | -8 | -0.3% | 240,700 |
| 2025/07/03 | 3,134 | 3,161 | 3,122 | 3,141 | +21 | +0.7% | 268,000 |
| 2025/07/02 | 3,146 | 3,151 | 3,120 | 3,120 | -21 | -0.7% | 279,800 |
| 2025/07/01 | 3,175 | 3,177 | 3,119 | 3,141 | -5 | -0.2% | 473,900 |
| 2025/06/30 | 3,130 | 3,159 | 3,120 | 3,146 | +28 | +0.9% | 636,100 |
| 2025/06/27 | 3,101 | 3,128 | 3,095 | 3,118 | -3 | -0.1% | 529,500 |
| 2025/06/26 | 3,116 | 3,126 | 3,100 | 3,121 | +1 | ±0% | 533,700 |
201～
250
件表示中 / 3978件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 413,000円 | +17.1% | +5.9% | 3.00% | 9.18倍 | 0.95倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 152,450円 | +19.1% | -10.3% | 0.00% | 8.88倍 | 2.34倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ロート | 253,200円 | +7.5% | -3.9% | 1.97% | 16.58倍 | 1.89倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| ツムラ | 378,300円 | +10.9% | -11.3% | 4.18% | 10.76倍 | 0.88倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 東和薬品 | 410,500円 | +11.1% | +6.8% | 2.07% | 9.40倍 | 1.14倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
